Results 11 to 20 of about 9,596 (243)

Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus. [PDF]

open access: yesFront Immunol, 2019
Current influenza vaccines are generally effective against highly similar (homologous) strains, but their effectiveness decreases markedly against antigenically mismatched (heterologous) strains. One way of developing a universal influenza vaccine with a
Shirai S   +8 more
europepmc   +2 more sources

Intratracheal synthetic CpG oligodeoxynucleotide causes acute lung injury with systemic inflammatory response [PDF]

open access: goldRespiratory Research, 2009
Bacterial genome is characterized by frequent unmethylated cytosine-phosphate-guanine (CpG) motifs. Deleterious effects can occur when synthetic oligodeoxynucleotides (ODN) with unmethylated CpG dinucleotides (CpG-ODN) are administered in a systemic ...
Sadatomo Tasaka   +10 more
openalex   +3 more sources

CpG oligodeoxynucleotides as mucosal adjuvants [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2015
Bacterial DNA comprising palindromic sequences and containing unmethylated CpG is recognized by toll-like receptor 9 of plasmacytoid dendritic cells (pDCs) and induces the production of interferon-α and chemokines, leading to the activation of a Th1 immune response. Therefore, synthetic equivalents of bacterial DNA (CpG oligodeoxynucleotides) have been
Iho, Sumiko   +2 more
openaire   +2 more sources

TLR 9 activation in dendritic cells enhances salmonella killing and antigen presentation via involvement of the reactive oxygen species. [PDF]

open access: yesPLoS ONE, 2010
Synthetic CpG containing oligodeoxynucleotide Toll like receptor-9 agonist (CpG DNA) activates innate immunity and can stimulate antigen presentation against numerous intracellular pathogens.
Amit Lahiri   +5 more
doaj   +1 more source

TLR9/NF-kB Pathway Regulates Brucella CpG DNA-mediated Cytokine Response in Human Peripheral Blood Mononuclear Cells [PDF]

open access: yesIranian Journal of Immunology, 2021
Background: It was reported that targeting the Toll-like receptor9(TLR9) signaling pathway can be a promising therapeuticstrategy forinterventions in various inflammatory and infectiousdiseases.
Yunzhi Peng   +3 more
doaj   +1 more source

CpG oligodeoxynucleotides as immunotherapy in cancer [PDF]

open access: yesUpdate on Cancer Therapeutics, 2008
Preclinical and early clinical trials indicate synthetic oligodeoxynucleotides containing unmethylated CG dinucleotides (CpG ODN) have potent immunostimulatory effects and can enhance the anti-cancer activity of a variety of cancer treatments. Synergy between CpG ODN and monoclonal antibodies has been noted in various preclinical models. Early clinical
Bernd, Jahrsdörfer, George J, Weiner
openaire   +2 more sources

Self-assembled immunostimulatory nanosphere combined with PD-L1 to enhanced cancer chemoimmunotherapy

open access: yesMaterials & Design, 2022
Induction of antigen-specific immune response by maturing dendritic cells (DCs) is a promising strategy for anti-tumor immunotherapy. However, the immunosuppressive tumor microenvironment (TME) and the ineffective tumor-associated antigen (TAAs ...
Haihui Wang   +8 more
doaj   +1 more source

Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections. [PDF]

open access: yesFront Immunol, 2016
Current influenza vaccines generate humoral immunity, targeting highly variable epitopes and thus fail to achieve long-term protection. T cells recognize and respond to several highly conserved epitopes across influenza serotypes.
Cheng WK   +4 more
europepmc   +3 more sources

Effect of molecular weight of polyethyleneimine on loading of CpG oligodeoxynucleotides onto flake-shell silica nanoparticles for enhanced TLR9-mediated induction of interferon-α

open access: goldInternational Journal of Nanomedicine, 2012
Yuvaraj Manoharan,1,* Qingmin Ji,2,* Tomohiko Yamazaki,2,3 Shanmugavel Chinnathambi,1 Song Chen,2,4 Ganesan Singaravelu,1 Jonathan P Hill,2 Katsuhiko Ariga,2,5 Nobutaka Hanagata3,6 1Department of Medical Physics, Anna University, Chennai, India ...
Nobutaka Hanagata   +8 more
openalex   +4 more sources

Home - About - Disclaimer - Privacy